Biotech

All Articles

ReNeuron leaving AIM exchange after skipping fundraising objective

.ReNeuron has signed up with the lengthy listing of biotechs to leave behind London's intention secu...

MBX declare IPO to take opposition to Ascendis into phase 3

.MBX Biosciences has included in the recent outbreak of IPO filings. The biotech, which submitted it...

FDA increases probe in to Lykos' MDMA tests: WSJ

.For Lykos Rehabs and also the firm's would-be MDMA-assisted therapy for trauma (PTSD), the hits jus...

Gene editor Tome laying off 131 laborers

.Only times after gene editor Volume Biosciences revealed secret working cuts, a more clear photo is...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Therapeutics is actually laying off an one-fourth of its own labor force as the oncology bio...

J &amp J apply for FDA authorization of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken one more measure toward realizing a return on its own $6.5 billion n...

Gain's phase 1 succeed leads means to prove Parkinson's medication's worth

.Increase Rehabs has actually prepared its own direct showing the effectiveness of its Parkinson's d...

Actinogen reports brand new phase 2 information to save clinical depression drug

.Actinogen Medical's chances-- and also stock rate-- have actually recoiled a little from earlier th...

Pfizer and also Main incorporate Quotient to multibillion-dollar equation

.Front Runner Pioneering and also Pfizer have included Quotient into their 10-program relationship, ...

Bayer pens $547M pact to push perimeters of noncoding RNA

.Bayer execs were eager to anxiety to Ferocious this summertime that the German pharma titan's appet...